AOD-9604 doesnt significantly impact blood glucose or insulin levels, unlike full growth hormone
Warfarin sodium was purchased from Tokyo Chemical Industry Co
Perhaps most significantly, not a single serious adverse event was attributed to AOD-9604 administration across the entire trial program
DSP / DSIP is intended for qualified research use only and is not positioned as a medicine, supplement, sleep aid, insomnia product, anxiety product, pain-support product, recovery product, or performance enhancer
This combination targets fat metabolism and energy production simultaneously, making it a popular choice for clients working toward weight management or fitness goals who want an added performance edge
Generic statements such as injection given are not sufficient